Marie-Anne Vandenhende

Author

Centre Hospitalier Universitaire de Bordeaux

Also Known As

C Valette, Camille Tumiotto, Cozzi-Lepri, Alessandro, F Bonnet, M C Pertusa, M. Vandenhende, Marie-Anne Vandenhende, Marie-Carmen Pertusa

Publications

430

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Bordeaux Université de Bordeaux Inserm Hôpital Pellegrin Bordeaux Population Health

About

Marie-Anne Vandenhende is an author at Centre Hospitalier Universitaire de Bordeaux specializing in medicine, drug resistance, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	45
2	Public Health	1	1	22
3	Epidemiology	1	1	22
4	Immunology	1	1	23
5	Medical Laboratory Science	1	1	22

Marie-Anne Vandenhende

Publications

304

Citations

H-Index

Page 1

	Year	Citations
Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000 Marie-Anne Vandenhende, Caroline Roussillon, Sandrine Hénard, PLoS ONE	2015	88
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy Lauren E. Cain, Michael S. Saag, Maya L. Petersen, International Journal of Epidemiology	2015	65
Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure Marie-Anne Vandenhende, Pantxika Bellecave, Patrícia Recordon-Pinson, PLoS ONE	2014	48
Risk of Virological Failure in HIV-1-Infected Patients Experiencing Low-Level Viraemia under Active Antiretroviral Therapy (ANRS C03 Cohort Study) Marie-Anne Vandenhende, Adélaïde Perrier, Fabrice Bonnet, Antiviral Therapy	2014	33
Structure-Analysis of the HIV-1 Integrase Y143C/R Raltegravir Resistance Mutation in Association with the Secondary Mutation T97A Sandrine Reigadas, Bernard Masquelier, Christina Calmels, Antimicrobial Agents and Chemotherapy Hiv-1 IntegraseImmunodeficienciesGeneticsImmunologyAntiviral Drug	2011	23
Detection of Low-Frequency HIV Type 1 Reverse Transcriptase Drug Resistance Mutations by Ultradeep Sequencing in Naive HIV Type 1-Infected individuals Pantxika Bellecave, Patrícia Recordon-Pinson, Jennifer Papuchon, AIDS Research and Human Retroviruses Genetic EpidemiologyGenotypic ResistanceDrug ResistanceHuman RetrovirusGenotypic Resistance Testing	2013	22
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older Sara Lodi, Dominique Costagliola, Caroline Sabin, JAIDS Journal of Acquired Immune Deficiency Syndromes	2017	15
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection E. Mériglier, C. Rivoisy, Mojgan Hessamfar, Journal of Antimicrobial Chemotherapy	2020	10

Page 1